Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Identifying Barriers to Buprenorphine Treatment for Patients with Opioid Use Disorder Among Anesthesiologists and Pain Practitioners: A Survey Study

Identifying Barriers to Buprenorphine Treatment for Patients with Opioid Use Disorder Among... Objective The aim of the study is to investigate barriers to opioid use disorder (OUD) care among acute and chronic pain physicians and advanced practice providers, including hypothesized barriers of lack of interest in OUD care and stigma toward this patient population. Methods The study used an anonymous 16-item online survey through Google Forms. Respondents were 153 health practitioners across the United States and Canada, all of whom are registered in one of several pain or anesthesia professional societies. Data were analyzed with descriptive and categorical statistics. Results The most common barriers include “lack of appropriate clinical environment for prescribing by both acute and chronic pain practitioners” (48%) and “lack of administrative/departmental support” (46%). A total of 32% of respondents reported that OUD care was important but they were not interested in doing more, while 28% of practitioners believed that they treat patients with OUD differently than others in a negative way. More males reported “difficulty” in treating OUD as a barrier (45% vs 25%). Chronic pain practitioners reported poor payor mix as a barrier twice as often as their acute pain colleagues. In free response, lack of multidisciplinary OUD care was a notable barrier. Conclusions The top barriers to OUD treatment were clinical environment, departmental support, difficulty in treating the condition, and payor mix, supporting the hypotheses. Given an OUD patient scenario, 55% of acute pain physicians and 73% of chronic pain physicians expressed a willingness to prescribe buprenorphine. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Addiction Medicine Wolters Kluwer Health

Identifying Barriers to Buprenorphine Treatment for Patients with Opioid Use Disorder Among Anesthesiologists and Pain Practitioners: A Survey Study

Download PDF
7 pages

Loading next page...
 
/lp/wolters-kluwer-health/identifying-barriers-to-buprenorphine-treatment-for-patients-with-0JF3udxlIJ

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wolters Kluwer Health
Copyright
Copyright © 2022 American Society of Addiction Medicine
ISSN
1932-0620
eISSN
1935-3227
DOI
10.1097/adm.0000000000001066
Publisher site
See Article on Publisher Site

Abstract

Objective The aim of the study is to investigate barriers to opioid use disorder (OUD) care among acute and chronic pain physicians and advanced practice providers, including hypothesized barriers of lack of interest in OUD care and stigma toward this patient population. Methods The study used an anonymous 16-item online survey through Google Forms. Respondents were 153 health practitioners across the United States and Canada, all of whom are registered in one of several pain or anesthesia professional societies. Data were analyzed with descriptive and categorical statistics. Results The most common barriers include “lack of appropriate clinical environment for prescribing by both acute and chronic pain practitioners” (48%) and “lack of administrative/departmental support” (46%). A total of 32% of respondents reported that OUD care was important but they were not interested in doing more, while 28% of practitioners believed that they treat patients with OUD differently than others in a negative way. More males reported “difficulty” in treating OUD as a barrier (45% vs 25%). Chronic pain practitioners reported poor payor mix as a barrier twice as often as their acute pain colleagues. In free response, lack of multidisciplinary OUD care was a notable barrier. Conclusions The top barriers to OUD treatment were clinical environment, departmental support, difficulty in treating the condition, and payor mix, supporting the hypotheses. Given an OUD patient scenario, 55% of acute pain physicians and 73% of chronic pain physicians expressed a willingness to prescribe buprenorphine.

Journal

Journal of Addiction Medicine – Wolters Kluwer Health

Published: Mar 24, 2023

References

  • Products—vital statistics rapid release—provisional drug overdose data
    Ahmad, FB; Rossen, LM; Sutton, P
  • Products—data briefs—number 329—November 2018
    Hedegaard, H; Miniño, AM; Warner, M
  • TIP 63: Medications for opioid use disorder
  • Key substance use and mental health indicators in the United States: results from the 2019
    Lipari, RN; Park-Lee, E
  • Why aren’t physicians prescribing more buprenorphine?
    Huhn, AS; Dunn, KE
  • Acute pain management in opioid-tolerant patients: a growing challenge
    Huxtable, CA; Roberts, LJ; Somogyi, AA
  • Evidence brief: barriers and facilitators to use of medications for opioid use disorder
    Mackey, K; Veazie, S; Anderson, J
  • National Academies of Sciences, Engineering, and Medicine. Medications for Opioid Use Disorder Save Lives
  • Evidence brief: barriers and facilitators to use of medications for opioid use disorder authors: evidence synthesis program evidence brief: barriers and facilitators to use of medications for OUD evidence synthesis program
    Helfand, M; Mackey, K; Veazie, S; Anderson, J; Bourne, D; Peterson, K
  • The multidisciplinary approach to the management of substance abuse
    Sdrulla, AD; Chen, G
  • Legal action center | emergency: hospitals can violate federal law by…. Legal Action Center
    Yeboah-Sampong, S; Weber, E; Friedman, S
  • Drugs-related death soon after hospital-discharge among drug treatment clients in Scotland: record linkage, validation, and investigation of risk-factors
    White, SR; Bird, SM; Merrall, ELC
  • Primary care physicians’ perspectives on the prescription opioid epidemic
    Kennedy-Hendricks, A; Busch, SH; McGinty, EE
  • Influence of implicit—bias training on the cultural competency of police officers—ProQuest
    Whitfield, M
  • “They look at us like junkies”: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City
    Muncan, B; Walters, SM; Ezell, J
  • Buprenorphine—an attractive opioid with underutilized potential in treatment of chronic pain
    Khanna, IK; Pillarisetti, S
  • Woodruff MTLBESASWAO. dismantling buprenorphine policy can provide more comprehensive addiction treatment
    Alex, E
  • Understanding buprenorphine for use in chronic pain: expert opinion
    Webster, L; Gudin, J; Raffa, RB
  • Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 National Survey on Drug Use and Health
    Han, B; Compton, WM; Blanco, C
  • Primary care and the opioid-overdose crisis—buprenorphine myths and realities
    Wakeman, SE; Barnett, ML
  • Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel
    Kohan, L; Potru, S; Barreveld, AM